Renal cell carcinoma (RCC) is one of the most important urological tumors and is one of the most common cancer diseases worldwide. Unfortunately, the treatment options are very limited due to resistances. Non-invasive physical plasma (NIPP) is currently becoming a promising and very well tolerated treatment option for cancer. NIPP represents a highly energized gas and induc es varying antioncogenic cell responses in tumor cells. And also in t he case of RCC, NIPP treatment has great potential to enhance and supplement existing anticancer treatment options. Outstanding characteristics of NIPP treatment are 1) a precise and local effect on the treated tissue and 2) an almost exclusive effect on treated tumor cells without side effects. This allows an enormously large therapeutic window and makes the combination o f NIPP treatment and classical therapy appear particularly promising. In addition to R CC, plasma oncology offers an extremely innovative physical treatme nt method for future oncology in general. This brief review article summarizes the current knowledge on the potential use of NIPP in RCC therapy.
Europäische Union (2020) ECIS—European Cancer Information System. https://ecis.jrc.ec.europa.eu
Fiebig, J. and Kraywinkel, K. (2019) Epidemiologie des Nierenzellkarzinoms in Deutschland. Der Onkologe, 25, 483-487. https://doi.org/10.1007/s00761-019-0580-7
Doehn, C., Grünwald, V., Steiner, T., Follmann, M., Rexer, H. and Krege, S. (2016) Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms. Deutsches Ärzteblatt International, 113, 590-596.
Leitlinienprogramm Onkologie (2017) Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms. http://leitlinienprogramm-onkologie.de/Nierenzellkarzinom.85.0.html
Hu, J., Ugnat, A.-M. and die Canadian Cancer Registries Epidemiology Research Group (2005) Active and Passive Smoking and Risk of Renal Cell Carcinoma in Canada. European Journal of Cancer, 41, 770-778. https://doi.org/10.1016/j.ejca.2005.01.003
Theis, R.P., Dolwick Grieb, S.M., Burr, D., Siddiqui, T. and Asal, N.R. (2008) Smoking, Environmental Tobacco Smoke, and Risk of Renal Cell Cancer: A Population-Based Case-Control Study. BMC Cancer, 8, 387. https://doi.org/10.1186/1471-2407-8-387
Parker, A.S., Cerhan, J.R., Janney, C.A., Lynch, C.F. and Cantor, K.P. (2003) Smoking Cessation and Renal Cell Carcinoma. Annals of Epidemiology, 13, 245-251. https://doi.org/10.1016/S1047-2797(02)00271-5
Renehan, A.G., Tyson, M., Egger, M., Heller, R.F. and Zwahlen, M. (2008) Body-Mass Index and Incidence of Cancer: A Systematic Review and Meta-Analysis of Prospective Observational Studies. The Lancet, 371, 569-578. https://doi.org/10.1016/S0140-6736(08)60269-X
Flaherty, K.T., et al. (2005) A Prospective Study of Body Mass Index, Hypertension, and Smoking and the Risk of Renal Cell Carcinoma (United States). Cancer Causes & Control: CCC, 16, 1099-1106. https://doi.org/10.1007/s10552-005-0349-8
Choi, M.Y., Jee, S.H., Sull, J.W. and Nam, C.M. (2005) The Effect of Hypertension on the Risk for Kidney Cancer in Korean Men. Kidney International, 67, 647-652. https://doi.org/10.1111/j.1523-1755.2005.67137.x
Port, F.K., Ragheb, N.E., Schwartz, A.G. and Hawthorne, V.M. (1989) Neoplasms in Dialysis Patients: A Population-Based Study. American Journal of Kidney Diseases, 14, 119-123. https://doi.org/10.1016/S0272-6386(89)80187-8
Gago-Dominguez, M., Yuan, J.M., Castelao, J.E., Ross, R.K. and Yu, M.C. (2001) Family History and Risk of Renal Cell Carcinoma. Cancer Epidemiology, Biomarkers & Prevention, 10, 1001-1004.
Clague, J., et al. (2009) Family History and Risk of Renal Cell Carcinoma: Results from a Case-Control Study and Systematic Meta-Analysis. Cancer Epidemiology, Biomarkers & Prevention, 18, 801-807. https://doi.org/10.1158/1055-9965.EPI-08-0601
Moch, H., Cubilla, A.L., Humphrey, P.A., Reuter, V.E. and Ulbright, T.M. (2016) The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs Part A: Renal, Penile, and Testicular Tumours. European Urology, 70, 93-105. https://doi.org/10.1016/j.eururo.2016.02.029
Cohen, H.T. and McGovern, F.J. (2005) Renal-Cell Carcinoma. The New England Journal of Medicine, 353, 2477-2490. https://doi.org/10.1056/NEJMra043172
Kaatsch, P., et al. (2019) Niere. Krebs in Deutschland für, 2015/2016, 106-109.
Smaldone, M.C., et al. (2012) Small Renal Masses Progressing to Metastases under Active Surveillance: A Systematic Review and Pooled Analysis. Cancer, 118, 997-1006. https://doi.org/10.1002/cncr.26369
Siva, S., Pham, D., Gill, S., Corcoran, N.M. and Foroudi, F. (2012) A Systematic Review of Stereotactic Radiotherapy Ablation for Primary Renal Cell Carcinoma. BJU International, 110, 737-743. https://doi.org/10.1111/j.1464-410X.2012.11550.x
MacLennan, S., et al. (2012) Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer. European Urology, 61, 972-993. https://doi.org/10.1016/j.eururo.2012.02.039
El Dib, R., Touma, N.J. and Kapoor, A. (2012) Cryoablation vs Radiofrequency Ablation for the Treatment of Renal Cell Carcinoma: A Meta-Analysis of Case Series Studies.BJU International, 110, 510-516. https://doi.org/10.1111/j.1464-410X.2011.10885.x
Ljungberg, B., et al. (2019) European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. European Urology, 75, 799-810. https://doi.org/10.1016/j.eururo.2019.02.011
MacLennan, S., et al. (2012) Systematic Review of Perioperative and Quality-of-Life Outcomes Following Surgical Management of Localised Renal Cancer. European Urology, 62, 1097-1117. https://doi.org/10.1016/j.eururo.2012.07.028
Gill, I.S., et al. (2007) Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors. The Journal of Urology, 178, 41-46. https://doi.org/10.1016/j.juro.2007.03.038
Lane, B.R. and Gill, I.S. (2010) 7-Year Oncological Outcomes after Laparoscopic and Open Partial Nephrectomy. The Journal of Urology, 183, 473-479. https://doi.org/10.1016/j.juro.2009.10.023
Alt, A.L., Boorjian, S.A., Lohse, C.M., Costello, B.A., Leibovich, B.C. and Blute, M.L. (2011) Survival after Complete Surgical Resection of Multiple Metastases from Renal Cell Carcinoma. Cancer, 117, 2873-2882. https://doi.org/10.1002/cncr.25836
Eggener, S.E., Yossepowitch, O., Kundu, S., Motzer, R.J. and Russo, P. (2008) Risk Score and Metastasectomy Independently Impact Prognosis of Patients with Recurrent Renal Cell Carcinoma. The Journal of Urology, 180, 873-878. https://doi.org/10.1016/j.juro.2008.05.006
Motzer, R.J., Bander, N.H. and Nanus, D.M. (1996) Renal-Cell Carcinoma. The New England Journal of Medicine, 335, 865-875. https://doi.org/10.1056/NEJM199609193351207
Hartmann, J.T. and Bokemeyer, C. (1999) Chemotherapy for Renal Cell Carcinoma. Anticancer Research, 19, 1541-1543.
Minasian, L.M., Motzer, R.J., Gluck, L., Mazumdar, M., Vlamis, V. and Krown, S.E. (1993) Interferon alfa-2a in Advanced Renal Cell Carcinoma: Treatment Results and Survival in 159 Patients with Long-Term Follow-Up. Journal of Clinical Oncology, 11, 1368-1375. https://doi.org/10.1200/JCO.1993.11.7.1368
Yang, J.C., et al. (2003) Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients with Metastatic Renal Cancer. Journal of Clinical Oncology, 21, 3127-3132. https://doi.org/10.1200/JCO.2003.02.122
Motzer, R.J., et al. (2007) Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma. The New England Journal of Medicine, 356, 115-124. https://doi.org/10.1056/NEJMoa065044
Motzer, R.J., et al. (2013) Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma. The New England Journal of Medicine, 369, 722-731. https://doi.org/10.1056/NEJMoa1303989
Escudier, B., et al. (2007) Bevacizumab plus Interferon Alfa-2a for Treatment of Metastatic Renal Cell Carcinoma: A Randomised, Double-Blind Phase III Trial. The Lancet, 370, 2103-2111. https://doi.org/10.1016/S0140-6736(07)61904-7
Motzer, R.J., et al. (2009) Overall Survival and Updated Results for Sunitinib Compared with Interferon Alfa in Patients with Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology, 27, 3584-3590. https://doi.org/10.1200/JCO.2008.20.1293
Albiges, L., et al. (2012) Complete Remission with Tyrosine Kinase Inhibitors in Renal Cell Carcinoma. Journal of Clinical Oncology, 30, 482-487. https://doi.org/10.1200/JCO.2011.37.2516
Chow, E., Zeng, L., Salvo, N., Dennis, K., Tsao, M. and Lutz, S. (2012) Update on the Systematic Review of Palliative Radiotherapy Trials for Bone Metastases. Clinical Oncology, 24, 112-124. https://doi.org/10.1016/j.clon.2011.11.004
Lutz, S. (2012) The Role of Radiation Therapy in Controlling Painful Bone Metastases. Current Pain and Headache Reports, 16, 300-306. https://doi.org/10.1007/s11916-012-0271-1
Rades, D., Weber, A., Bartscht, T., Bajrovic, A., Karstens, J.H. and Schild, S.E. (2014) A New Prognostic Factor for the Survival of Patients with Renal Cell Carcinoma Developing Metastatic Spinal Cord Compression. Strahlentherapie und Onkologie, 190, 667-670. https://doi.org/10.1007/s00066-014-0616-2
Dziggel, L., Segedin, B., Podvrsnik, N.H., Oblak, I., Schild, S.E. and Rades, D. (2014) A Survival Score for Patients with Brain Metastases from Less Radiosensitive Tumors Treated with Whole-Brain Radiotherapy Alone. Strahlentherapie und Onkologie, 190, 54-58. https://doi.org/10.1007/s00066-013-0394-2
Moisan, M., Barbeau, J., Moreau, S., Pelletier, J., Tabrizian, M. and Yahia, L.H. (2001) Low-Temperature Sterilization Using Gas Plasmas: A Review of the Experiments and an Analysis of the Inactivation Mechanisms. International Journal of Pharmaceutics, 226, 1-21. https://doi.org/10.1016/S0378-5173(01)00752-9
Gay-Mimbrera, J., García, M., Tejera, B., Rodero, A., Antonio Vélez García, N. and Ruano, J. (2016) Clinical and Biological Principles of Cold Atmospheric Plasma Application in Skin Cancer. Advances in Therapy, 33, 894-909. https://doi.org/10.1007/s12325-016-0338-1
Hoffmann, C., Berganza, C. and Zhang, J. (2013) Cold Atmospheric Plasma: Methods of Production and Application in Dentistry and Oncology. Medical Gas Research, 3, 21. https://doi.org/10.1186/2045-9912-3-21
Lee, H., Shon, C., Kim, Y., Kim, S., Kim, G. and Kong, M.G. (2009) Degradation of Adhesion Molecules of G361 Melanoma Cells by a Non-Thermal Atmospheric Pressure Microplasma. New Journal of Physics, 11, Article ID: 115026. https://doi.org/10.1088/1367-2630/11/11/115026
Von Woedtke, T., Kramer, A. and Weltmann, K.-D. (2008) Plasma Sterilization: What Are the Conditions to Meet This Claim? Plasma Processes and Polymers, 5, 534-539. https://doi.org/10.1002/ppap.200800013
Laroussi, M. (2008) The Biomedical Applications of Plasma: A Brief History of the Development of a New Field of Research. IEEE Transactions on Plasma Science, 36, 1612-1614. https://doi.org/10.1109/TPS.2008.917167
Ziuzina, D., Patil, S., Cullen, P.J., Keener, K.M. and Bourke, P. (2014) Atmospheric Cold Plasma Inactivation of Escherichia coli, Salmonella enterica Serovar Typhimurium and Listeria monocytogenes Inoculated on Fresh Produce. Food Microbiology, 42, 109-116. https://doi.org/10.1016/j.fm.2014.02.007
Heinlin, J., et al. (2011) Plasma Applications in Medicine with a Special Focus on Dermatology. The Journal of the European Academy of Dermatology and Venereology, 25, 1-11. https://doi.org/10.1111/j.1468-3083.2010.03702.x
Leonarduzzi, G., Sottero, B. and Poli, G. (2010) Targeting Tissue Oxidative Damage by Means of Cell Signaling Modulators: The Antioxidant Concept Revisited. Pharmacology & Therapeutics, 128, 336-374. https://doi.org/10.1016/j.pharmthera.2010.08.003
Isbary, G., et al. (2010) A First Prospective Randomized Controlled Trial to Decrease Bacterial Load Using Cold Atmospheric Argon Plasma on Chronic Wounds in Patients. The British Journal of Dermatology, 163, 78-82. https://doi.org/10.1111/j.1365-2133.2010.09744.x
Mohd Nasir, N., Lee, B.K., Yap, S.S., Thong, K.L. and Yap, S.L. (2016) Cold Plasma Inactivation of Chronic Wound Bacteria. Archives of Biochemistry and Biophysics, 605, 76-85. https://doi.org/10.1016/j.abb.2016.03.033
Dezest, M., et al. (2017) Mechanistic Insights into the Impact of Cold Atmospheric Pressure Plasma on Human Epithelial Cell Lines. Scientific Reports, 7, Article No. 41163. https://doi.org/10.1038/srep41163
Keidar, M., et al. (2012) Cold Atmospheric Plasma in Cancer Therapy. Physics of Plasmas, 20, Article ID: 057101. https://doi.org/10.1063/1.4801516
Yan, D., Sherman, J.H. and Keidar, M. (2017) Cold Atmospheric Plasma, a Novel Promising Anti-Cancer Treatment Modality. Oncotarget, 8, 15977-15995. https://doi.org/10.18632/oncotarget.13304
Xia, J., et al. (2019) Cold Atmospheric Plasma Induces Apoptosis of Melanoma Cells via Sestrin2-Mediated Nitric Oxide Synthase Signaling. Journal of Biophotonics, 12, 1-14. https://doi.org/10.1002/jbio.201800046
Kim, S.J., Chung, T.H., Bae, S.H. and Leem, S.H. (2010) Induction of Apoptosis in Human Breast Cancer Cells by a Pulsed Atmospheric Pressure Plasma Jet. Applied Physics Letters, 97, Article ID: 023702. https://doi.org/10.1063/1.3462293
Koensgen, D., et al. (2017) Cold Atmospheric Plasma (CAP) and CAP-Stimulated Cell Culture Media Suppress Ovarian Cancer Cell Growth—A Putative Treatment Option in Ovarian Cancer Therapy. Anticancer Research, 37, 6739-6744. https://doi.org/10.21873/anticanres.12133
Kim, J.Y., et al. (2011) Apoptosis of Lung Carcinoma Cells Induced by a Flexible Optical Fiber-Based Cold Microplasma. Biosensors & Bioelectronics, 28, 333-338. https://doi.org/10.1016/j.bios.2011.07.039
Ishaq, M., Evans, M.D.M. and Ostrikov, K.K. (2014) Atmospheric Pressure Gas Plasma-Induced Colorectal Cancer Cell Death Is Mediated by Nox2-ASK1 Apoptosis Pathways and Oxidative Stress Is Mitigated by Srx-Nrf2 Anti-Oxidant System. Biochimica et Biophysica Acta, 1843, 2827-2837. https://doi.org/10.1016/j.bbamcr.2014.08.011
Laroussi, M. (2009) Low-Temperature Plasmas for Medicine? IEEE Transactions on Plasma Science, 37, 714-725. https://doi.org/10.1109/TPS.2009.2017267
Dobrynin, D., Fridman, G., Friedman, G. and Fridman, A. (2009) Physical and Biological Mechanisms of Direct Plasma Interaction with Living Tissue. New Journal of Physics, 11, Article ID: 115020. https://doi.org/10.1088/1367-2630/11/11/115020
Sensenig, R., et al. (2011) Non-Thermal Plasma Induces Apoptosis in Melanoma Cells via Production of Intracellular Reactive Oxygen Species. Annals of Biomedical Engineering, 39, 674-687. https://doi.org/10.1007/s10439-010-0197-x
Partecke, L.I., et al. (2012) Tissue Tolerable Plasma (TTP) Induces Apoptosis in Pancreatic Cancer Cells in Vitro and in Vivo. BMC Cancer, 12, 473. https://doi.org/10.1186/1471-2407-12-473
Ishaq, M., Evans, M. and Ostrikov, K. (2014) Effect of Atmospheric Gas Plasmas on Cancer Cell Signaling. International Journal of Cancer, 134, 1517-1528. https://doi.org/10.1002/ijc.28323